Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer-Reference-Cited by-同舟云学术

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

Published:2015-06 Issue:6 Volume:26 Page:1223-1229
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Deutsch E.,Le Péchoux C.,Faivre L.,Rivera S.,Tao Y.,Pignon J.-P.,Angokai M.,Bahleda R.,Deandreis D.,Angevin E.,Hennequin C.,Besse B.,Levy A.,Soria J.-C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/6/1223/16699757/mdv105.pdf

Reference31 articles.

1. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

2. Concurrent chemoradiotherapy in non-small cell lung cancer;O'Rourke;Cochrane Database Syst Rev.,2010

3. Individual patient data (IPD) meta-analyses (MA) of chemotherapy (CT) in locally advanced non-small cell lung cancer (NSCLC). 1st European Lung Cancer Conference, Geneva, April 2008;Le Pechoux;J Thorax Oncol,2008

4. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines;Kim;Cancer Res.,2005

5. Molecular pathology of lung cancer:key to personalized medicine;Cheng;Mod Pathol.,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment;Frontiers in Immunology;2024-07-19

2. Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe;Journal of Experimental & Clinical Cancer Research;2024-06-06

3. Combining radiation and systemic therapy;Palliative Radiation Oncology;2024

4. Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe;2023-12-23

5. Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way;Phytochemistry Reviews;2023-10-11